Background The efficacy of vaginal progesterone for preventing preterm birth and adverse
perinatal outcomes in singleton gestations with a short cervix has been questioned after …

Preterm birth (PTB), which occurs in about 12% of pregnancies worldwide, is the main cause
of neonatal morbidity and mortality. Symptomatic treatment of pregnancies presenting in …

Background Preterm birth is a global health priority. Using a progestogen during high-risk
pregnancy could reduce preterm birth and adverse neonatal outcomes. Methods We did a …

ISUOG Practice Guidelines: role of ultrasound in twin pregnancy ISUOG Practice Guidelines:
role of ultrasound in twin pregnancy Ultrasound Obstet Gynecol. 2016 Feb;47(2):247-63. doi …

Summary Background Every year, 1· 1 million babies die from prematurity, and many
survivors are disabled. Worldwide, 15 million babies are born preterm (< 37 weeks' …

Objective To assess the efficacy of vaginal progesterone for the prevention of preterm birth
and neonatal morbidity and mortality in asymptomatic women with a twin gestation and a …

Pregnancy involves a complex interplay between maternal neuroendocrine and
immunological systems in order to establish and sustain a growing fetus. It is thought that the …

Objectives Women with a sonographic short cervix in the mid‐trimester are at increased risk
for preterm delivery. This study was undertaken to determine the efficacy and safety of using …

OBJECTIVE: To determine whether the use of vaginal progesterone in asymptomatic women
with a sonographic short cervix (≤ 25 mm) in the midtrimester reduces the risk of preterm …

Objective To determine the risks of stillbirth and neonatal complications by gestational age
in uncomplicated monochorionic and dichorionic twin pregnancies. Design Systematic …